This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. It serves as a key intermediate in the creation of molecules that target specific biological pathways, often in the treatment of central nervous system disorders. Its structural features, including the trifluoromethyl group and the pyrrolopyridine core, make it valuable for enhancing the pharmacokinetic properties of potential therapeutics. Researchers also explore its use in designing compounds with improved binding affinity to receptors or enzymes, which is crucial for developing more effective and selective drugs. Additionally, it may be employed in medicinal chemistry studies to investigate structure-activity relationships, aiding in the optimization of drug-like properties.